|
GBR 2019
COI 1.17 %
*
Breed relevant health information:
Degenerative myelopathy (DM)
N/N (clear)
-
9/11/2020
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Good / A2 / 1-3 / A / 5-10 (no >6/hip)
-
1/1/2021
Progressive retinal atrophy (prcd-PRA)
N/mut (carrier)
|
|
FIN 2012
COI 1.64 %
*
Breed relevant health information:
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
-
21/1/2014
|
|
|||
|
NOR 2015
COI 0.79 %
*
Breed relevant health information:
Degenerative myelopathy (DM)
N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Mild / C1 / 9-12 / C / 26-35
Progressive retinal atrophy (prcd-PRA)
N/mut (carrier)
|
||
FIN 2014
COI 3.09 %
Breed relevant health information:
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
-
23/9/2015
|
|||
FRA 2016
COI 1.17 %
Breed relevant health information:
Degenerative myelopathy (DM)
N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Mild / C1 / 9-12 / C / 26-35
-
22/11/2018
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
|
FIN 2007
COI 4.26 %
*
Breed relevant health information:
Hips
Fair / B1 / 4-6 / B / 11-18
-
14/1/2009
Other health issues and screening results:
Epilepsy
Year of death:
2013
Cause of death:
Epilepsy
|
|
|
|||
|
|
||
FIN 2007
COI 1.40 %
*
Breed relevant health information:
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
-
30/10/2009
|
Date of birth | Year of death | Cause of death | Canine Multifocal Retinopathy 3 (CMR3) | Degenerative myelopathy (DM) | Elbows | Glycogen storage disease type II (Pompe disease) (GSDII) | Hips | Progressive retinal atrophy (prcd-PRA) | Result of general cardiovascular health checks | |
---|---|---|---|---|---|---|---|---|---|---|
Parents | ||||||||||
Aegirsson May Gamgee (Imp Fra)
|
5 Aug 2016 | N/N (clear) | N/N (clear) | Mild / C1 / 9-12 / C / 26-35 | N/N (clear) | |||||
Degenerative myelopathy (DM):
N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Mild / C1 / 9-12 / C / 26-35
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Tabanyaruu Wihta Kaamos (AI)
|
13 Aug 2019 | N/N (clear) | N/N (clear) | Good / A2 / 1-3 / A / 5-10 (no >6/hip) | N/mut (carrier) | |||||
Degenerative myelopathy (DM):
N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Good / A2 / 1-3 / A / 5-10 (no >6/hip)
Progressive retinal atrophy (prcd-PRA):
N/mut (carrier)
|
||||||||||
Siblings | ||||||||||
Tabanyaruu Aurora Aamu
|
12 Dec 2021 | |||||||||
Tabanyaruu Aurora Ahkera
|
12 Dec 2021 | clear by parentage | ||||||||
Glycogen storage disease type II (Pompe disease) (GSDII):
clear by parentage
|
||||||||||
Tabanyaruu Aurora Akseli
|
12 Dec 2021 | |||||||||
Half siblings (sire) | ||||||||||
Half siblings (dam) | ||||||||||
TabanyaRuu Xuvi Elvis
|
1 Nov 2019 | N/N (clear) | ||||||||
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
tabanyaruu xuvi Kyrie
|
1 Nov 2019 | |||||||||
TabanyaRuu Xuvi Teemu
|
1 Nov 2019 | N/N (clear) | ||||||||
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Offspring |